LYMPHOMA, B-CELL, MARGINAL ZONE
Clinical trials for LYMPHOMA, B-CELL, MARGINAL ZONE explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, B-CELL, MARGINAL ZONE trials appear
Sign up with your email to follow new studies for LYMPHOMA, B-CELL, MARGINAL ZONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets Hard-to-Treat blood cancers
Disease control Not yet recruitingThis early-stage study tests a new drug called LY4152199 in people with B-cell cancers like lymphoma that have not responded to prior treatments. The main goals are to find the safest dose and see if the drug can shrink tumors. About 215 adults will take part, and those who benef…
Matched conditions: LYMPHOMA, B-CELL, MARGINAL ZONE
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 26, 2026 11:06 UTC
-
New hope for tough blood cancers: experimental drug MTM-H-001 enters human trials
Disease control Not yet recruitingThis study tests an experimental drug called MTM-H-001 in about 69 adults whose B-cell cancers (like certain lymphomas or leukemias) have come back or stopped responding to treatment. The main goal is to check safety and find the right dose, while also seeing if it shrinks tumors…
Matched conditions: LYMPHOMA, B-CELL, MARGINAL ZONE
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 18, 2026 12:03 UTC